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Superior limb salvage with endovascular therapy in
octogenarians with critical limb ischemia
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and Maciej L. Dryjski, MD,b Buffalo, NY
Objective: The goal of this study is to compare our results following open and endovascular infrainguinal revasculariza-
tions in patients>80 and<80 years old presenting with critical limb ischemia (CLI) and to determine if limb salvage (LS)
attempt is justified in patients >80 with CLI, especially following endovascular interventions.
Methods: A retrospective analysis of 344 consecutive patients (399 limbs) who presented with CLI and underwent
infrainguinal open or endovascular (EV) revascularizations between June 2001 and December 2007 was performed.
Patients >80 (89 patients, 101 limbs) and <80 years old (255 patients, 298 limbs) were compared for demographics,
characteristics, patency, limb salvage, sustained clinical success (preservation of limb, freedom from target extremity
revascularization (TER), and resolution of symptoms), secondary clinical success (preservation of limb and resolution of
symptoms), overall improvement (preservation of limb, improvement of symptoms), and survival.
Results: Patients >80 were more likely to be nonambulatory and have coronary artery disease, whereas those <80 were
more likely to have hypertension, hyperlipidemia, dialysis-dependence, active tobacco abuse, and taking beta-blockers.
Primary amputation rates were similar between two groups (<80 vs >80, 6.7% vs 8.1%, P  .530). Perioperative
mortality was significantly worse in >80 group in the open-treated group (16.2% vs 2.9%, P  .009), whereas it was
similar in EV-treated patients (3.1% vs 0.6%, P .197). The patency rates were similar between groups, however, LS was
significantly better in >80 EV-treated patients than <80 group, whereas it was similar between groups in open-treated
patients. Sustained clinical success, secondary clinical success, and overall improvement rates were similar between age
groups. Endovascular-treated patients in >80 had significantly better overall improvement than those who were treated
by open revascularization (24-month overall improvement 83%  5% vs 61%  9%, P  .043). Multivariate analysis
showed diabetes, infrapopliteal intervention, presence of gangrene, nonambulatory status, dialysis-dependence, and
runoff status being associated with limb loss whereas age being > or <80 was not. Age, coronary artery disease, chronic
obstructive pulmonary disease, nonambulatory status, and dialysis-dependence were found to be independently associ-
ated with decreased survival.
Conclusions: Our results suggest that revascularization in patients >80 with CLI is justified, especially when an
endovascular intervention can be accomplished. Although limb salvage following endovascular interventions were better
in the >80 group, sustained clinical success, and secondary clinical success rates were similar following open and
endovascular interventions in both age groups. Open procedures carry a high perioperative mortality in the >80 age
group and should be avoided if possible. ( J Vasc Surg 2009;50:305-16.)The increase in the octogenarian and nonagenarian
population has resulted in an increased number of patients
in this age group who present with critical limb ischemia
(CLI).1 Several studies suggest that comparable limb sal-
vage can be achieved with bypass procedures in patients
over 80,2-5 which may increase survival if amputation can
be avoided.6,7 However, these studies often included pa-
tients who were ambulatory or functionally independent,
and the results may not be applicable to patients over 80
years of age who present with CLI and have a limited
functional capacity. Morbidity and mortality is high in this
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doi:10.1016/j.jvs.2009.01.004elderly patient population,8,9 while the increased use of
endovascular interventions has enabled vascular surgeons
to attempt limb salvage in a larger proportion of these
patients.8,10,11 Similar limb salvage and sustained clinical
benefit was observed in a recent series of patients who
underwent endovascular and open revascularizations, with
both groups having better outcomes than those who were
initially treated conservatively.8
The maintenance of functional capacity and indepen-
dent living status has been suggested as important goals for
the outcome of lower extremity revascularization in elderly
patients, however, previous series have reported that im-
proved functional capacity is infrequent.2,11 Taylor et al12
suggested that in patients who are unsuitable for open
surgery, the advantage of angioplasty in maintenance of
ambulation and independent status were lost after 12 and 3
months, respectively, compared with primary amputation.
In addition, patients who were treated with angioplasty had
poorer survival than the primary amputation group.
We have increasingly adopted an endovascular-first ap-
proach, whenever feasible for all patients presenting with
CLI in all ages since 2002. The goal of this study is to
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dovascular revascularizations in patients 80 and 80
years old presenting with critical limb ischemia, and to
determine if limb salvage (LS) attempt is justified in pa-
tients 80 with CLI, especially following endovascular
interventions.
MATERIAL AND METHODS
Design. All consecutive patients who presented to the
Veterans’ Administration Western New York Healthcare
System between June 1, 2001 and December 31, 2007
with critical limb ischemia (Rutherford category 4-6)13
who underwent infrainguinal revascularization either by
endovascular or open bypass procedures were identified,
and retrospectively analyzed from our prospectively main-
tained database. Patients were grouped into those 80 or
80 years old.
Methodology. The patients’ demographics, comor-
bidities, clinical presentation, number of runoff vessels,
preoperative functional status (ambulatory, ambulatory at
home, wheelchair-bound, independent, nonambulatory
transfers only, bedridden), noninvasive arterial studies,
other imaging studies, details of the procedures performed,
the most distal level of intervention, postoperative course,
length of stay (LOS), follow-up arterial studies, and status
of their limbs on last follow-up were recorded. The original
TransAtlantic Society Consensus (TASC) classification of
the endovascular-treated lesions14 was used until January
2007, after which TASC II classification15 was used.
All patients were seen by a member of the anesthesia
department prior to any intervention scheduled in the
operating room. In addition to the routine preanesthetic
evaluation (including a history and physical examination),
this clinic coordinates with the primary care services to
medically optimize surgical patients prior to their proce-
dures. The American Heart Association/American College
of Cardiology guidelines16,17 were used to identify the
high-risk patients based on the presence or absence of
major clinical predictors, functional capacity, and surgery-
specific risk. Patients who met the requirements for periop-
erative beta blockade were administered metoprolol, which
was titrated to the desired effect prior to the surgical
procedure, and metoprolol was continued intra- and post-
operatively. The beta-blocker protocol was more strictly
adhered to after 2003. Patients were not routinely started
on statins, but were continued if already started by their
primary physician preoperatively.
All endovascular procedures were performed by vascu-
lar surgeons in the operating room using the OEC 9800
system (General Electric Medical Systems, Salt Lake City,
Utah). The decision to proceed with endovascular inter-
vention or open bypass was made by the vascular surgeon,
with increasing complex endovascular interventions over
the study period. Primary amputation was offered primarily
to bedridden patients, however, revascularization was per-
formed if the patient or family adamantly refused a major
amputation, and if the patient did not have severe flexion
contractures or foot sepsis. Balloon angioplasty with provi-sional stenting for flow-limiting dissections, or residual
stenosis, and recoil of 30% was used for most interven-
tions. Debulking procedures as an adjunct were used in a
small number of patients (Excimer laser atherectomy; Spec-
tranetics Corp, Colorado Springs, Colo, 25 patients; Silver-
Hawk atherectomy; Foxhollow Inc, RedwoodCity, Calif, 8
patients).
All patients were followed by clinical assessment and by
our vascular laboratory during the first postoperative visit
(1-4 weeks), and at 3, 6 months, and every 6 months
thereafter. All patients with open wounds were followed in
vascular surgery wound clinic until wounds were healed.
Angiography was performed when noninvasive studies sug-
gested restenosis (defined as an elevated ratio of greater
than three times the velocity of the more proximal normal
segment) or occlusion, or adequacy of foot perfusion was in
question. Reinterventions were performed for maintaining
patency, or when clinically indicated. We perform reinter-
ventions for asymptomatic restenoses both on endovascu-
lar- or open-treated patients to maintain patency, however,
do not reintervene for asymptomatic occlusions. Society for
Vascular Surgery (SVS) reporting standards for lower ex-
tremity arterial procedures were followed.13
Definitions. Target extremity revascularization (TER)
was defined as any intervention (endovascular or open)
performed on the extremity to maintain assisted-primary,
secondary patency, or a new revascularization (open or
endovascular). Sustained clinical success was defined as
clinical improvement without the need for TER and with-
out major amputation. Clinical improvement was defined
as upward shift of one Rutherford category13 for those with
rest pain, and of two categories for those with tissue loss, in
combination with hemodynamic improvement of ankle-
brachial index (ABI) of at least 0.1. Secondary clinical
success was defined as clinical improved with or without
TER, and major amputation. We also assessed overall clin-
ical improvement, which we defined as no need for major
amputation, improving wounds with excellent pain con-
trol, and ability to maintain treatment on an outpatient
basis. A patent runoff vessel was defined as an infrapopliteal
vessel without a hemodynamically significant (50%) an-
giographic stenosis distal to the treated site, and the num-
ber of adequately patent runoff vessels (0-3) was calculated
after all interventions were completed for that limb. In-line
flowwas defined as reinstitution of uninterrupted flow by at
least one non-diseased infrapopliteal runoff vessel (anterior
tibial, posterior tibial or peroneal artery) to the foot follow-
ing revascularization. If the only runoff vessel was peroneal
artery, this was noted. Primary amputation was defined as a
major (supramalleolar) amputation which was performed
without any revascularization attempt.
Statistical analysis. Data analysis was performed us-
ing SPSS 16.0 software (SPSS Inc, Chicago, Ill). Kaplan-
Meier analysis, and log rank test were used to compare
groups for sustained clinical success, secondary clinical suc-
cess, overall improvement, primary patency (PP), assisted-
primary patency (APP), secondary patency (SP), limb sal-
vage (LS), and overall survival on an intent-to-treat basis.
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tion. Demographic comparisons were made using two-
tailed Fisher exact test for categorical variables, and by
two-tailed t test for continuous variables. Cox-proportional
hazard model was used to estimate the risk ratio and the
95% confidence interval. The stepwise Cox-proportional
hazardmodel was used for themultivariate analysis with the
entry alpha 0.20 and stay alpha 0.10. All P values were
two sided. All P values were considered significant if .05.
Institutional Review Board approval was obtained for the
study.
RESULTS
A total of 344 patients (399 limbs, 99% males) were
included. There were 89 patients (101 limbs) who were
80 years old and 255 patients (298 limbs) who were80
years old. Demographic and preoperative characteristics of
patients are shown in Table I. Patients in the80-year-old
group were more likely to be nonambulatory and have
coronary artery disease (CAD), whereas patients80 years
old were more likely to have hyperlipidemia, be dialysis-
dependent, be an active smoker, and taking beta-blockers.
Indication for intervention was not significantly different
between groups (80 vs 80; rest pain 13% vs 20%, P 
.104; non-healing ulcer 38% vs 37%, P  .906; gangrene
49% vs 43%, P  .248). There were more patients with
gangrene in the endovascular-treated group (49.6% vs
37.7%, P  .02), whereas non-healing ulcers was similar
(36.0% vs 37.9%, P  1.0). In the open group, patients
80 were more likely to have gangrene (51.4% vs 34.1%,
P  .059), whereas presence of gangrene was similar in
endovascular-treated patients (50.0% vs 48.4%, 80 vs
80, P  .883).
The procedures performed in each group are listed in
Table II. Although more patients in 80 group had open
procedures, this was not statistically significant (36.6% vs
46.3%,80 vs80; P .104). The percentage of patients
having infrapopliteal interventions were similar between
Table I. Demographics, comorbidities, and clinical
presentation in patients
80 80 P value
CAD 73% 59% .017
Hypertension 79% 91% .022
DM 58% 76% .750
CVD 17% 29% .560
COPD 17% 26% .136
Hyperlipidemia 50% 68% .001
CRI 32% 30% .802
ESRD 0% 12% .001
Smoker (active) 10% 47% .001
Beta-blocker use 42% 57% .008
Non-ambulatory 41% 30% .05
CAD,Coronary artery disease;DM, diabetes mellitus;CVD, cerebrovascular
disease;HTN, hypertension;COPD, chronic obstructive pulmonary disease;
CRI, chronic renal insufficiency; ESRD, end-stage renal disease on dialysis.age groups (55.4% vs 48.3%,80 vs80; P .131). In theopen group, infrapopliteal revascularizations were margin-
ally more frequent in 80 group (79.6% vs 57.2%, P 
.057) whereas there was no difference in endovascular
group (80 vs 80; 43.8% vs 40.6%, P  .764). In the
80 group who had infragenicular bypasses, 62% were
performed using prosthetic grafts, whereas this was 46% in
the 80 group (P  .157). The reason for not using
autologous grafts were either due to unavailability or small
size (3 mm) of the available veins. The distribution of the
TASC classification of the endovascular-treated patients
was similar between two age groups. In 80 group, 13%
had TASC A, 5% had TASC B, 27% had TASC C, and 55%
had TASCD lesions, whereas these were 6%, 12%, 30%, and
52% in 80 group, respectively (P  .589).
Technical success was 97.7% and inline flow to the foot
was achieved in 93.1% in 80 group, and 96.6% in 80
group (P 1.0). Peroneal artery was the only runoff vessel
in 43.6% in 80 group and 22.1% in 80 group (P 
.001). Inline flow was established in 97.1% in open-treated
patients and 94.6% in endovascular-treated patients (P 
.318), and the runoff vessel was peroneal artery in 28.0% in
open-treated patients and 27.2% in endovascular-treated
patients (P .910). The in-line flow to the foot and runoff
status in endovascular and open revascularized patients in
different age groups are shown in Table III. The number of
patent runoff vessels were significantly more (P  .001) in
80 group for both open- and endovascular-treated pa-
Table II. Operations performed in groups
80 80
Open:
Femoral-AK popliteal bypass 3 26
(with iliac PTA/stent) (6)
Femoral-BK popliteal bypass 4 26
(with iliac PTA/stent) (6)
Fem-distal bypass 28 79
(with iliac/SFA PTA/stent) (4) (8)
Femoral endarterectomy 2 7
(with iliac/SFA PTA/stent) (4)
Total 37 138
Endovascular:
Femoropopliteal
PTA/S 36 94
(with iliac stent) (3) (18)
(unsuccessful) (2) (2)
Foxhollow 1
Total 36 95
Infrapopliteal
PTA/S 22 44
(with SFA stent) (9) (16)
(with iliac stent) (4)
(unsuccessful) (1)
Foxhollow 4
(with SFA stent) (1)
Excimer 6 17
(with SFA stent) (4) (6)
Total 28 65
Overall total 64 160
AK, Above-knee; BK, below-knee; SFA, superficial femoral artery; PTA/S,
percutaneous luminal angioplasty/stenting.tients.
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ipsilateral ABI increased from 0.43  0.28 to 0.82  0.21
in 80 group, and 0.41  0.25 to 0.88  0.16 in 80
group. The preoperative ABI was similar (P .575) in both
age groups, however, postoperative ABI was significantly
higher in 80 group (P  .027). The postoperative ABI
was significantly lower in 80 patients than 80 group
who underwent endovascular interventions (0.80 0.23 vs
0.92  0.14, P  .001), whereas they were similar after
open revascularizations (0.84  0.19 vs 0.84  0.18, P 
.960) in both age groups.
The LOS was similar between groups (80 vs80 age
groups, 8.1 10.6 vs 7.8 10.3, P .840). As expected,
LOS was significantly less in patents who underwent endo-
vascular interventions (10.9  11.5 vs 5.5  8.6, P 
.001), with no difference between age groups in either
treatment modality.
Postoperative complications are listed in Table IV. Any
complication or death was significantly more in80 group
(19.8% vs 10.1%, P  .015), both in the endovascular-
treated patients (80 vs 80, 10.9% vs 2.5%, P  .014),
and open-treated patients (35.1% vs 18.8%, P  .045).
Infectious complications (superficial and deep wound in-
fections, pneumonia) were limited to open-treated patients
and were similar between groups (80 vs 80, 5.4% vs
11.6%, P  .370). Postoperative major amputation rates
were similar between groups (2.0% vs 3.0%, P .737), with
no difference between subgroups. Postoperative mortality
was similar between age groups in endovascular-treated
patients (80 vs 80, 3.1% vs 0.6%, P  .197), however,
there was a significantly higher mortality among patients
80 who underwent open revascularizations (16.2% vs
2.9%, P  .007).
There were 13 30-day mortalities in this series; eight in
80 group and five in 80 group. Nine of these were in
the open group (six in 80 group), and four underwent
endovascular interventions (two in80 group). There was
only one bedridden patient (aged 81) in this group, who
died on day 29 in a nursing home after an endovascular
intervention for gangrene of his great toe. Additional four
Table III. Runoff status at the end of revascularization
procedures in groups
80 group 80 group P value
All patients
In-line flow 93.1% 96.6% .152
Peroneal-only runoff 43.6% 22.1% .001
Number of runoff vessels 1.2  0.6 1.5  0.8 .001
Endovascular-treated patients
In-line flow 90.1% 96.3% .106
Peroneal-only runoff 43.8% 20.6% .001
Number of runoff vessels 1.2  0.6 1.7  0.8 .001
Open-treated patients
In-line flow 97.3% 97.1% 1.0
Peroneal-only runoff 43.2% 23.9% .024
Number of runoff vessels 1.1  0.4 1.4  0.7 .019patients were nonambulatory (transfer only), three ofwhom were 80 (two had bypass, one had endovascular
intervention).
Five of the eight patients who died in the 80 group
were not on beta-blockers (due to severe chronic obstruc-
tive pulmonary disease [COPD]), and four of them were
not on statins. Five of the eight mortalities were due to
myocardial infarctions between 2 to 7 days after the index
procedure. Two of the remaining patients died of pneumo-
nia and one from an unknown cause on 18th postoperative
day in the nursing home.
Significantly more patients came from home in 80
group than 80 group (78% vs 65%, P  .018). Only 34%
of the 80 group was discharged to home, 29% were sent
back to a nursing home, 30% were sent to rehabilitation
centers, and 8% died in the hospital. In the80 group, 59%
were sent home, 18%were sent to nursing homes, 23%were
sent to rehabilitation centers, and 1% died in the hospital.
At last follow-up (mean 20.7 18.5 months), 51% of80
group who survived past 30 days were at home, 43%were in
nursing homes, 4% were in hospice, and 2% died while still
in hospital beyond 30 days. In the 80, 9% patients who
initially came from home eventually ended up in nursing
homes, 3% were sent to hospice, and only one patient (1%)
who was in a nursing home eventually went back to inde-
pendent living at home.
Ambulatory status of patients in both age groups before
the intervention and during last follow-up is shown on
Table V. There were more patients who were preopera-
tively nonambulatory in the 80 group, whereas there
were more patients who were wheelchair-bound but inde-
pendent in the 80 group. There were no significant
differences in ambulatory status at last follow-up in the80
group, whereas there were more patients who became
wheelchair-bound in the 80 group (26% vs 15%, P 
.079). Although the percentage of patients who were am-
bulatory were similar in 80 and 80 groups (56% vs
60%), nonambulatory patients were still more in the 80
group. In the 80 group, four patients who were ambula-
tory preoperatively became either wheelchair-bound, or
bedridden. On the contrary, one patient who was transfer-
only became ambulatory with assistive device, and 12 pa-
tients had significant improvement in their ambulatory
status, and became ambulatory outside the house. The
remaining patients stayed at their preoperative ambulatory
status. Of note, 11 of the 15 patients who were bedridden
and underwent revascularization had endovascular inter-
ventions, and only one died perioperatively, and eight did
not undergo an amputation, however, 1-year survival was
only 33% in this patient population.
The mean follow-up was 25.0  19.2 months. There
was no difference in patency rates between age groups. The
12-month and 24-month primary patency rates for endo-
vascular-treated patients were 78% 6% and 78% 6% for
80, and 73% 4% and 59% 5% for80 group patients
(P  .192), secondary patency rates were 91%  4% and
87%  6% for 80, and 88%  3% and 86%  3% for 80
(P .902). The 12-month and 24-month primary patency
rates for open-treated patients were 64% 9.6% and 39%
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patients (P  .167), secondary patency rates were 74% 
9% and 56% 11% for80, and 75% 4% and 71% 4%
for 80 (P  .395). Although the primary patency rates
were similar between open and endovascular-treated pa-
tients in80 group (P .714), this was significantly better
in 80 group (P  .011). The secondary patency rates
were significantly better for endovascular-treated patients
than open-treated patients, which remained significant in
both age groups (P  .005 for 80, P  .027 for 80
groups).
Primary amputation rates were similar during the study
period (80 vs80, 6.7% vs 8.1%, P .530). Limb salvage
rates in open-treated patients were similar in80 and80
age groups (12-month and 24-month LS rates, 77%  9%
and 61% 11% vs 81% 4% and 76% 4%, P .405, Fig
1), whereas the LS rate in 80 group was significantly
better than 80 group in endovascular-treated patients
(12- and 24-month LS rates, 93% 3% and 93% 3% vs
82%  3% and 77%  4%, P  .015, Fig 2). When the
dialysis patients were excluded, the LS rates in the
endovascular-treated patients were still better in the 80
than 80 group (24-month LS 93%  3% vs 80%  4%,
P  .041), whereas they were still similar in open-treated
patients (12-month LS 77% 9% vs 83% 4%, P .274).
Incidentally, the LS rates in infrageniculate bypasses using
autologous vein grafts were only marginally better than
those performed using synthetic grafts (24-month LS
Table IV. Perioperative (30-day) complications after reva
EV (%)
Non-fatal MI 2 (3.1)
Pneumonia 0
Bleeding 0
Infection superficial 0
Infection deep 0
Pseudoaneurysm 1 (1.6)
Limb ischemia (early graft/stent occlusion) 1 (1.6)
Bowel obstruction 0
Stroke 1 (1.6)
Death 2 (3.1)
EV, Endovascular; MI, myocardial infarction.
Table V. Ambulatory status of patients in both age group
80 group
Preoperative Postoper
Ambulatory (limited to home) 60% (43%) 56% (3
Wheelchair, independent 5% 10%
Nonambuatory, transfers only 27% 23%
Bedridden 9% 12%
aP  .05 vs preoperative 80 group.
bP  .01 vs preoperative 80 group.
cP  .01 vs postoperative 80 group.80%  5% vs 62%  7%, P  .084), with no differencebetween age groups. Multilevel interventions did not have
a significant impact on LS rates in both age groups (data
not shown).
Freedom from TER was similar between age groups
(P  .829) and between endovascular- and open-treated
patients in the 80 group (P  .538), however, freedom
from TER was significantly better among endovascular-
treated patients than open-treated patients in 80 group
(24-month freedom from TER 85% 5% vs 54% 11.5%,
P  .007). In the endovascular group, freedom from TER
was marginally better in 80, than 80 patients (24-
month 85%  5% vs 66%  5%, P  .108). The sustained
clinical success rates, secondary clinical success rates, and
overall improvement rates were also similar between age
groups (Table VI). However,80 endovascular group had
significantly better overall improvement than those who
were treated by open revascularization (24-month overall
improvement 83%  5% vs 56%  9%, P  .023). There
were no significant differences between treatment groups
among 80 patients.
In patients who had infrageniculate interventions (n 
231), the LS was marginally better in patients who had
bypass using autologous vein grafts than other grafts (P 
.084), but it was not different from endovascular-treated
patients (P  .233). However, TER (P  .03), sustained
clinical success (P  .002), secondary clinical success (P 
.002), and overall improvement (P  .03) were signifi-
cantly better in those who had bypasses with autologous
rizations
80 group 80 group
Open (%) EV (%) Open (%)
1 (2.7) 0 2 (1.4)
1 (2.7) 0 1 (0.7)
1 (2.7) 1 (0.6) 2 (1.4)
1 (2.7) 0 11 (8.0)
0 0 3 (2.2)
0 1 (0.6) 0
3 (8.1) 1 (0.6) 2 (1.4)
0 0 1 (0.7)
0 0 0
6 (16.2) 1 (0.6) 4 (2.9)
ore the intervention, and during last follow-up
80 group
P Preoperative Postoperative P
.667 70%a (31%) 60% (19%) .182
.283 15%b 26%c .079
.623 13%b 12%c 1.0
.645 2%b 2%c 1.0scula
s bef
ative
0%)veins than those who had bypasses using other grafts or
e ind
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ever, in the 80 group, LS was marginally better in those
who had endovascular interventions than those who had
bypasses with either autologous vein grafts or synthetic
grafts (P  .134). However, sustained clinical success rate
was similar between endovascular and autologous vein graft
group, both of which were better than prosthetic bypass
group (P  .049), which was also similar for both second-
ary clinical success rates (P  .075) and overall clinical
improvement rates (P .005). The patients in the younger
age group had the best results with autologous vein grafts
(Table VII, online only). When we compared the age
groups, the only difference was in the endovascular-treated
patients, in whom the80 group had better LS rates (P
.02), freedom from TER (P  .087), sustained clinical
success (P  .037), secondary clinical success (P  .022),
and overall clinical success rates (P  .012) than those in
the80 group, whereas these rates were similar in patients
treated with autologous vein or synthetic grafts (P  0.12
for all) (Table VII, online only).
There were four amputations in patients80 who had
endovascular revascularizations (n  64), two within 30
days, one after 1 month, and one at 3 months following the
intervention. Three patients had patent endovascular-
treated segments, but amputation was necessary due to
follow-up limb salva
181260
1.0
0.8
0.6
0.4
0.2
0.0
Age group 0 mo 6 mo 12 mo 18
≥80  37 19 16 13
<80  138 105 88 71
Fig 1. Limb salvage following open revascularizations i
each time interval is shown below the figure. Hashed lininfections leading to extensive tissue loss. The fourth pa-tient presented with occlusion of the popliteal artery, result-
ing in irreversible ischemia and amputation. One patient had
failed revascularization, refused further interventions, and
died at 3months with rest pain. There were nine amputations
(24%) in the 80 group who had open revascularizations
(n  37). Five were in patients who had femoral-distal
bypasses using polytetrafluoroethylene (PTFE) grafts (one
was patent), three had great saphenous vein (GSV) bypasses
(one was patent), and one who underwent femoral endar-
terectomy for rest pain, developed foot infection and had
an amputation 24 months after the initial procedure.
The overall survival was significantly worse in 80
group, with no difference between endovascular- and
open-treated patients. The 12-month, 36-month, and 60-
month survival rates were 57% 5%, 37% 6%, and 29%
7% for 80 group, and 77%  2%, 56%  3%, and 39% 
4% for80 group (P.001). The survival in80 patients
who survived the open revascularization was similar to
those 80 years old (12-month and 36-month survival,
65% 9% and 40% 9.6% in80, vs 78% 4% and 59%
5% in 80, P  .120). The survival remained significantly
worse in endovascular-treated 80 patients who survived
the intervention (12-month and 36-month survival, 61%
6% and 40%  8% in 80, vs 79%  3% and 54%  5% in
onth
3630
Age <80-censored
Age >80-censored
Age <80
Age >80
age group
P=0.405 
24 mo 30 mo 36 mo 
12 8 8 
59 51 43 
0 and80 age groups. The number of patients at risk at
icates standard error 10%.ge m
24
 mo 
 
 
n880, P  .019).
.2
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 2 Dosluoglu et al 311Univariate analysis showed diabetes, dialysis-dependence,
gangrene, level of intervention being infrapopliteal, nonam-
bulatory status, number of runoff vessels, and COPD being
associated with poorer LS rates (Table VIII). However, on
multivariate analysis, only diabetes, infrapopliteal interven-
tions, nonambulatory status, dialysis-dependence, presence
of gangrene, and number of runoff were found to be
associated with limb loss (Table IX), but not age 80,
COPD, and peroneal-artery-only runoff.
Mortality during follow-up was associated with ad-
vanced age, nonambulatory status, CAD, diabetes mellitus
follow-up limb salva
181260
1.0
0.8
0.6
0.4
0.2
0.0
Age group 0 mo 6 mo 12 mo 18
≥80  64 43 36 26
<80  160 126 106 74
Fig 2. Limb salvage following endovascular intervention
at each time interval is shown below the figure.
Table VI. Sustained clinical success (SusCS), secondary cl
and freedom from target extremity revascularization (f-TE
(EV) or open interventions
SusCS Sec
12 mo 24 mo 12 mo
80 EV (n  64) 61%  6% 61%  6% 73%  6%
80 EV (n  160) 59%  4% 49%  5% 69%  4%
P value .265
80 Open (n  37) 52%  9% 38%  9.7% 66%  8%
80 Open (n  138) 63%  4% 58%  5% 76%  4%
P value .111(DM) , COPD, dialysis-dependence, and presence of gan-grene on univariate analysis (Table X), however, multivar-
iate analysis showed age 80, CAD, COPD, nonambula-
tory status, and dialysis-dependence being independently
associated with poorer survival (Table XI), whereas DM,
CVD, presence of gangrene, level of most distal interven-
tion, and type of intervention were not.
DISCUSSION
The oldest old (80) is the fastest growing component
of the world’s population, and the United States was esti-
mated to have had approximately 13% (9.2 million people)
onth
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80 and80 age groups. The number of patients at risk
l success (SecCS), overall clinical improvement (OCI),
patients 80 and 80 who underwent endovascular
OCI f-TER
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 6% 83%  5% 83%  5% 85%  5% 85%  5%
 4% 79%  3% 76%  4% 80%  4% 66%  5%
74 .314 .108
 9% 66%  8% 56%  9% 67  9.5% 54%  11.5%
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57%
71%of the world’s over 80 population in 2001.18 This naturally
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vascular surgeons and is now a relatively common problem
in a modern vascular surgery practice.
Major amputation in the elderly is associated with
Table VIII. Univariate analysis (Cox regression) for limb
salvage
Variable P  2
Hazard
ratio
95% hazard
ratio
confidence
limits
Age 0.2884 0.725 0.400 1.313
Level of intervention 0.0003 0.423 0.264 0.675
Ambulatory status 0.0103 1.802 1.149 2.827
HTN 0.5383 0.862 0.538 1.382
DM 0.0009 2.392 1.429 4.004
CAD 0.0777 1.518 0.955 2.415
Hyperlipidemia 0.0490 0.644 0.416 0.998
COPD 0.0609 0.530 0.273 1.030
CVD 0.2607 0.703 0.381 1.299
Dialysis-dependence 0.0054 2.326 1.283 4.218
Gangrene .0001 2.567 1.632 4.038
Peroneal artery-only runoff 0.7530 0.926 0.575 1.493
Number of runoff vessels 0.0009 0.504 0.336 0.755
Type of revascularization 0.3997 1.208 0.778 1.876
CAD,Coronary artery disease;DM, diabetes mellitus;CVD, cerebrovascular
disease;HTN, hypertension;COPD, chronic obstructive pulmonary disease.
Table IX. Multivariate analysis (stepwise Cox regression)
for limb salvage
Variable P  2
Hazard
ratio
95% hazard
ratio confidence
limits
Level of intervention 0.0369 0.582 0.350 0.968
Ambulatory status 0.0484 1.588 1.003 2.514
DM 0.0246 1.846 1.082 3.149
Dialysis-dependence 0.0121 2.160 1.184 3.943
Gangrene 0.0049 1.967 1.227 3.154
Number of runoff vessels 0.0233 0.599 0.385 0.933
DM, Diabetes mellitus.
Table X. Univariate analysis (Cox regression) for survival
Variable P  2
Hazard
ratio
95% hazard
ratio confidence
limits
Age 0.0004 1.732 1.280 2.345
Level of intervention 0.3212 0.869 0.658 1.147
Ambulatory status .0001 2.143 1.612 2.849
HTN 0.5365 1.104 0.807 1.509
DM 0.0034 1.557 1.157 2.095
CVD 0.1713 1.261 0.905 1.758
CAD .0001 2.091 1.531 2.856
Hyperlipidemia 0.0888 0.784 0.593 1.038
COPD .0001 1.834 1.356 2.482
Dialysis-dependence 0.0526 1.554 0.995 2.428
Gangrene 0.0012 1.588 1.201 2.100
Type of revascularization 0.5116 0.908 0.681 1.211
CAD,Coronary artery disease;DM, diabetes mellitus;CVD, cerebrovascular
disease;HTN, hypertension;COPD, chronic obstructive pulmonary disease.increased overall morbidity and mortality2 and worse out-come compared with younger patients.19 Also, the costs
associated with major amputation was estimated to be
higher than the cost for a successful revascularization.20,21
Open reconstructions have acceptable outcomes in good
risk patients over 80,2-5 compared with younger patients,
however, postoperative morbidity and mortality remains
significant, ranging from 2% to 20%. Reports of lower
mortality rates often favored patients who were ambula-
tory, independent, and lower surgical risk than those re-
porting higher mortality rates. Plecha et al9 reported 9%
mortality in patients 80 undergoing infrainguinal recon-
struction for claudication or CLI, and the 30-day mortality
for patients having femoro-femoral bypass was 19%. Brosi
et al8 reported 20% 30-day mortality in a consecutive
patient series, which was significantly higher than the 1.9%
in those 80 years old. In another study by Pomposelli et
al,2 the 30-day mortality was 2.3%, however, 96% of the
patients had independent living status, and 92% were am-
bulatory preoperatively. Our 30-day mortality in patients
80 who underwent open bypass procedures was 16.2%,
which was significantly higher than the 2.9% in those 80,
and than the 3.1% in those who underwent endovascular
interventions in the same age group. However, it was
similar to the mortality reported by Brosi et al,8 who
included both low- and high-risk patients in their study.
Increased perioperative usage of beta-blockers22,23 and
statins24,25 may potentially play an even more important
role in the octogenarian population as the mortality associ-
ated with these procedures seems excessive in our experi-
ence.
We have adopted an endovascular-first approach to our
patients presenting with CLI, and noted a decrease in the
primary amputation rate and overall limb salvage, without a
significant impact on survival.26 This is similar to other
groups, and is pertinent to older patients, since endovascu-
lar interventions have been associated with less cardiovas-
cular morbidity, lower infection rates, and a shorter length
of stay.27,28 We found that in the80 group, patients who
underwent endovascular revascularization for the treat-
ment of CLI had a significantly lowermortality rate at 3.1%,
similar to the previously reported 2% to 12%.2-4,8,10
The limb salvage rates in open treatment groups were
Table XI. Multivariate analysis (stepwise Cox regression)
for survival
Variable P  2
Hazard
ratio
95% hazard
ratio confidence
limits
Age 0.0004 1.805 1.304 2.499
Ambulatory status .0001 1.789 1.337 2.393
DM 0.0873 1.312 0.961 1.790
CAD 0.0009 1.736 1.254 2.403
COPD .0001 2.205 1.603 3.032
Dialysis-dependence 0.0124 1.849 1.142 2.992
Gangrene 0.0581 1.327 0.990 1.779
CAD, Coronary artery disease; DM, diabetes mellitus; COPD, chronic
obstructive pulmonary disease.similar between the two age groups, however, the LS rate
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vascular revascularizations than those 80 years, which
remained valid even when dialysis patients in the 80
group were excluded. To our knowledge, this is the first
study reporting superior LS rates in octogenarians than
nonoctogenarians with endovascular interventions. Al-
though there was likely a significant selection bias for the
type of revascularization in this study, it is hard to explain
this difference based only on this bias. When we com-
pared the two age groups who underwent endovascular
interventions, we found that patients in 80 group had
marginally fewer diabetics (59% vs 73%, P  .079), fewer
active smokers (8% vs 39%, P  0.001), and fewer dialysis-
dependent patients (0% vs 13%, P  0.001). No difference
in gangrene and infrapopliteal interventions was noted
among this age group. However, bedridden status was
more frequent in the older group (9% vs 3%, P  .081).
These factors may have contributed to the results in addi-
tion to the selection bias for endovascular-treated cases. It is
of note that the TASC classification of the treated lesions
was TASC C or D in 82% of both age groups, with no
difference between groups.
The use of prosthetic grafts, especially in the infra-
geniculate group was noted to be high in the study popu-
lation, however, this was a consecutive patient series, and
reflects our patient population with lack of adequate veins
for infrageniculate bypass. We found that patients who had
infrageniculate bypass using vein grafts overall performed
better than those who had bypasses using other grafts and
endovascular interventions. However, in the 80 group,
patients who had endovascular interventions either per-
formed better (LS and freedom from TER), or similar
(sustained clinical success, secondary clinical success and
overall improvement) to those who had bypasses using
autologous grafts. In this age group, patients who had
bypasses using other conduits performed worse in terms of
clinical success rates than endovascular-treated patients or
those who had bypasses using autologous veins. These
results were mainly due to the fact that the outcomes in
80 group who had infrageniculate endovascular interven-
tions were significantly better than the younger patients,
although the results with bypasses using any type of con-
duits were similar. These results suggest that endovascular
interventions should be preferred in the octogenarians who
need infrageniculate revascularizations whenever feasible,
even in patients who have TASCC orD lesions and suitable
veins, due to the less morbidity and mortality involved.
Although we do not advocate limb salvage attempt in
bedridden patients, we have performed revascularization
procedures in nonambulatory patients, some of whomwere
bedridden. Adamant refusal of an amputation by a mentally
competent patient or the next of kin is not rare in our
practice, and unless the patient had severe flexion contrac-
tures or advanced infection or tissue loss, we have per-
formed (mostly endovascular) revascularizations in selected
cases. Although the survival was very poor in these patients,
over half of them did not undergo an amputation, before
they died.Limb salvage by itself does not necessarily indicate a
clinical benefit, since maintenance of independence and
ambulatory status, need for reinterventions, and resolution
of symptoms, were also suggested as important factors for
assessing and comparing outcomes.2,5,11We found that the
sustained clinical success in those 80 and 80 were
similar, and was not different in those who had open or
endovascular interventions. When need for TER was not
considered, the secondary clinical success rates were also
similar between age groups, with no difference in the 80
groups between endovascular and open groups. These re-
sults were somewhat better than the recent study by Brosi
et al,8 and similar to the primary clinical success of 64% to
79% in other reports,3,10,11 although the criteria were not
as strict in those studies.
Parameters that define success in previous studies in-
cluded mortality and limb salvage, as well as full resolution
of symptoms and freedom from repeat revascularizations.8
However, factors such as freedom from pain, or improved
pain control, and preserving a sense of body wholeness
were frequently ignored. We therefore evaluated in both
patient groups, the overall clinical improvement of symp-
toms, healing of wounds, freedom from pain, and ability to
be managed as outpatients. There was no difference be-
tween the two age groups in overall symptom improvement
by last follow-up. However, patients in the80 group who
had endovascular interventions had significantly better re-
sults than those who underwent open interventions. We
surmise that overall improvement is a more important
assessment of outcome in this age group than freedom from
reintervention and should be routinely assessed in the
elderly patients undergoing interventions.
Survival of the older group was significantly worse both
in the endovascular- and open-treated patients. The 12, 36
and 60-month survival in our 80 group was 59%, 40%,
and 25%, which was similar to the study by Brosi et al8
(12-month survival 68% in endovascular, 63% in open-
treated group), and Salas et al10 (24-month survival 59%, vs
55% in our endovascular-treated patients), both of which
consist of patients treated mostly by endovascular means.
Studies on open reconstructions have much better overall
survival rates, with 5-year survival between 42% and
44%.2,11 Our multivariate analysis showed age 80, CAD,
COPD, dialysis-dependence, and nonambulatory status
being independently associated with poorer survival. This
concurs with Taylor et al29 (nonambulatory status, end-
stage renal disease on dialysis [ESRD], age 70, COPD,
CAD) in their multivariate analysis of 1000 limb revascu-
larizations in 841 patients who underwent endovascular or
open procedures for CLI. In addition, both studies found
that age was not an independent risk factor for limb loss,
but DM, ESRD, smoking and ambulatory status were.
Although preoperative functional status is closely re-
lated to outcomes, an increasing number of patients who
have limited independence and ambulatory function are
being referred for evaluation. The ideal approach to these
patients creates not only a medical, but also an ethical
dilemma. Taylor et al12 reviewed their experience with
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functional status, who were unsuitable for open surgery
(n  131) to those who underwent primary amputation
(n  183). The LS rate was 63% in 12 months, and the
percutaneous luminal angioplasty (PTA) group had signif-
icantly lower rates of ambulatory failure, and loss of inde-
pendence, but had significantly lower overall survival than
the amputation group. In addition, the ambulation advan-
tage lasted only 12 months, and maintenance of indepen-
dent living lasted only 3 months. It is important to point
out that the 30-day mortality in their amputation group
was only 4.4%, which is significantly less than the previous
reports. The 30-day mortality rate in our80 population is
33% following primary amputation, and 15% in all patients
who present with CLI and undergo primary amputation.
All mortalities in our octogenarians who underwent pri-
mary amputations occurred in either hospice or nursing
homes due to their extremely poor medical condition,
unrelated to the procedures. The 24-month survival in
nonambulatory patients80, who underwent primary am-
putation was 42% in our patients, whereas it was 39% in
endovascular-treated nonambulatory patients (data not
shown). Thus, our experience does not support Taylor et
al’s findings that angioplasty is associated with increased
mortality, although there is no significant survival benefit
outside of the perioperative period.
Postoperative complications were significantly higher
in 80 group, both in the open- and endovascular-treated
patients. Dick et al30 recently reported similar results with
major complications occurring in 11.1% of patients 80,
whereas this was 1.8% in younger patients (P .001). They
speculated that this was due to differences in vessel wall
stiffness, calcification, as well as having proportionately
more women (65% vs 40%, P  .001) in the older group
who had more comorbidities and likely smaller vessels.
Although our population was almost exclusively a male
group, our results were very similar, suggesting that the
vessel wall characteristics (vessel wall calcification, stiffness)
may play a more important role than gender for the in-
creased complication rates seen in older patients. Brosi et
al8 suggested that octogenarians with CLI had better re-
sults with revascularization, compared to those who were
conservatively managed. We believe that CLI should be
treated with an endovascular-first approach for octogenar-
ians.
There are some limitations of our study. It was a single
center, retrospective study from a prospectively maintained
database, and treatment allocation was made at the discre-
tion of the vascular surgeon. The endovascular first ap-
proach was increasingly used starting in 2002, with increas-
ing complexity as experience was gained. Another limitation
was that the study population was predominantly males
(99%), while most other studies predominantly (60% to
75%)2-5,8,10 had more females in their 80 groups. Our
results may therefore be skewed in the sense that we may be
treating higher risk mostly male patients with poorer pre-
operative functional capacity. Although the percentage of
patients who had nonautologous grafts was high, this didnot seem to affect the overall conclusions of our study.
Lastly, we did not perform any analysis using question-
naires (such as SF-36) to assess the quality of life as per-
ceived by the patients. However, a significant proportion of
our patients are not able to complete such extensive sur-
veys.
CONCLUSION
In conclusion, our results suggest that revascularization
in patients80 with CLI is justified, especially when an EV
intervention can be accomplished. Although limb salvage
following endovascular interventions was better in the80
group, sustained clinical success, and secondary clinical
success rates were similar following open and endovascular
interventions in both age groups. Open procedures carry a
high perioperative mortality in the 80 age group and
should be avoided as much as possible, even in patients with
TASC C and D lesions. Although age was associated with
poorer overall survival, it was not associated with limb loss.
Aggressive revascularization for attempted LS is justified in
patients 80 years old.
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DrEvanC. Lipsitz (Bronx, NY).We agree that efforts at limb
salvage are justified in patients over 80, as documented by several
studies including one done 20 years ago at our own institution. It
is also noteworthy that the authors have moved past the endpoints
of patency and limb salvage and attempted to gauge outcome with
quality of life and patient wholeness as described.
As we are all aware, older, sicker patients are going to have
worse outcomes. One way of looking at the data you presented, is
that there is a significant increase in perioperative mortality in both
groups, eightfold in the open group, but even sixfold in the
endovascular group. So several questions:
(1) How are patients selected for endovascular vs open
procedures? Are there strict criteria? Were there trends that
emerged?
(2) The mortality certainly would seem to be somewhat high,
not just in this study. Were there any subgroups that were at
especially high risk for morbidity/mortality in the over-80 group?
(3) Why was the limb salvage so much significantly better in
the over-80 groups when there seemed to be no difference for the(4)Were there any criteria, perhaps even including ambulatory
status that would suggest absolute contraindication to attempts at
limb salvage?
Dr Hasan H. Dosluoglu. Thank you, Dr Lipsitz, for your
insightful comments. About the selection criteria; as I mentioned,
these are almost exclusively my patients and I tried to select the
treatment that I thought was best for the patient at the time. In
addition, I think it is also a moving target over time, because it
probably changed as my experience increased. So there is certainly
a huge selection bias in this study.
In terms of mortality, before I actually looked at my data, if
somebody asked me what my mortality over 80 was, I would have
probably guessed 6%. I just never really realized that most of the
patients who actually do not make it to 30 days are octogenarians,
and I was surprised with my own 16% mortality in the open group.
Almost all of themwere due tomyocardial infarctions (MI)s within
a week to 2 weeks after the procedures; some of them were already
in nursing homes or rehab centers.
So I guess at this point I do not have great selection criteria for
selecting patients for revascularization vs primary amputation. But
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loss. And if somebody is bedridden, it seems obvious. Even then,
we all know that sometimes there are situations that it is not a
straightforward decision that a bedridden patient should have a
primary amputation. So I guess I would say that primary amputa-
tion could be considered in the bedridden patient, but then again,
I am sure I will still attempt limb salvage in some patients who are
nonambulatory or bedridden.
Why was endovascular so much better in the octogenarians? I
think it is related to the huge selection bias. We were choosing
bypass for only those who really could not otherwise have any other
option and we were pushing it, as we were pushing endovascular
for the limb salvage for those in whom it was feasible and reason-
able. We may have been a bit too aggressive in very risky patients.
And the limb salvage, therefore, was a result of that selection, and
being aggressive.
Dr Marat Goldenberg (Reading, Pa). I just have one ques-
tion. If you were to stratify the patients and compare the above-
knee procedures with open or endovascular to each other vs below
knee, being that those patients have much worse vascular disease,
do you think your results would not be so different? And with
patients who have severe vascular disease, infrapopliteal vascular
disease, the endovascular results perhaps would not be as good as
above knee.
DrDosluoglu. The infrapopliteal intervention independently
predicted limb loss, but it was really not because of the treatment
modality being bypass or endovascular. The results were not so
different.
As a matter of fact, I have to mention that a good number of
these patients who had absolutely no veins available were
treated with synthetic grafts to the infrapopliteal vessels. So this
is a disadvantaged group of patients. Endovascular is not such a
poor alternative to a synthetic graft distal bypass. Since these
were a consecutive patient series, I am not going to be able to
answer that very easily, because the alternatives are not always
endovascular vs a vein graft to a nondiseased infrapopliteal
vessel.
Dr R. Patterson (Providence, RI). Did you have any patients
who crossed over, who you attempted an endovascular approach
on and were either unsuccessful or their outcome was not what you
wanted and then you subsequently operated on them? And if so,
were their outcomes worse than people who would have had
primary surgery? In other words, did that make those patients
sicker or less satisfactory in their outcome?
Dr Dosluoglu. Especially in the octogenarians, there were no
crossovers in this study group. However, I just had one this week
that I first did an endovascular revascularization and then I per-
formed a bypass. It is not a very common occurrence. When you
have a crossing recanalization failure, then you can do the bypass
but bypass following successful endovascular revascularization is
not a frequent occurrence.
We recently presented a paper in Society for Clinical Vascular
Surgery (SCVS) suggesting that most of the limb losses in the endo-
vascular era actually occur in patientswith patent endovascular-treated
segments. I think this reflects the aggressiveness. Very few of those
actually are attempted to be salvaged by bypass because most of the
time there is actually no target for a bypass procedure. And I do not
think you lose much by doing endovascular at all.Dr Mark G. Davies (Houston, Tex). Were you able to
establish inline flow with each of your endovascular interventions?
This is the current premise of bypass surgery.
Dr Dosluoglu. I actually had that slide, but did not show it
for time constraints. I do not know the exact number, but in-line
flow to the foot was established in over 90% of these patients.
There was no difference in limb loss between those groups. And
the ones that did not have in-line flow established mostly were
those with rest pain.
Dr Davies. I suggest that one way to further stratify your data
might be to use the complexity grading system reported by Faries
et al in a previous paper on superficial femoral artery (SFA) inter-
ventions based on the number of levels intervened on. In that
report the number of levels intervened on was a poor prognostic
factor for outcomes.
Dr Dosluoglu. Just for clarification when I say infrapopliteal,
I meant themost distal was the infrapopliteal. So as a matter of fact,
a significant number of those had multilevel interventions, the
most distal of which was infrapopliteal.
Dr Krish Soundararajan (Philadelphia, Pa). Congratulations
on a very high volume as a single surgeon. I had one quick question
for you.
Intuitively I would have thought that the octogenarians would
have been the group to have aggressive limb salvage with atherec-
tomy as they may not be good surgical candidates. However, I see
that you have used the atherectomy device more often in younger
patients. Is this because of technical reasons or because octogenar-
ians do not have favorable outcome with atherectomy? Could you
share your insights in this regard? Thank you.
Dr Dosluoglu. It is interesting that you picked up on the
atherectomy because that is not a modality that I use a lot. And
apparently, there was a time that I used it and that reflects that time. I
really do not even remember that time, to be honest with you, at this
point, and I cannot really say anything. I do not use it right now.
Dr Robert Y. Rhee (Pittsburgh, Pa). Very interesting results.
I was wondering. What is your surveillance program for patients
who undergo these endovascular interventions? Is it similar to that
of your surgical bypass patients?
Dr Dosluoglu. Actually, we are very aggressive. We bring
them in postoperatively and then at 3 months, 6 months, and every
6 months thereafter. We duplex them and then we do ankle-
brachial indices (ABIs) and assess them clinically.
Of course, I have to admit it is not always easy to image the
infrapopliteal vessels by duplex. So when the technicians are not
sure, we have a low threshold for angiograms for infrapopliteal
interventions especially when there is a clinical suspicion of stag-
nation of ulcer healing or something like that.
Dr Rhee. Do you use a specific criteria?
Dr Dosluoglu. You mean for duplex criteria?
Dr Rhee. Yes.
Dr Dosluoglu. The velocity criteria we would go with three
times the normal velocity increase over the stented segment.
DrRhee.Would you intervene on asymptomatic patients who
develop abnormalities by duplex scanning?
Dr Dosluoglu. If it is a severe disease, if it is more than 70%,
yes. We start watching them closer when they are 50% or above,
and then we would intervene even if it is asymptomatic over 70% to
80%, yes. But it is very rare. Intervention in patients with asymp-
tomatic restenoses is a very rare event.
.001 .001
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clinical success (susCS), secondary clinical success (secCS),
underwent infrageniculate revascularizations following end
vein grafts (AVG) or other grafts (OTH) in both age grou
LS
12 mo 24 mo
EV (n  94) 77%  5% 72%  5%
AVG (n  68) 82%  5% 80%  5%
OTH (n  69) 71%  6% 62%  7%
P value .248
80 EV (n  29) 93%  5% 93%  5%
80 AVG (n  12) 78%  14% 65%  17%
80 OTH (n  20) 72%  12% 62%  14%
P value .134
80 EV (n  65) 70%  6% 64%  7%
80 AVG (n  6) 83%  5% 83%  5%
80 OTH (n  49) 71%  7% 62%  8%
P value .109m target extremity revascularization (f-TER), sustained
and overall clinical improvement (OCI) rates in patients who
ovascular interventions, bypass procedures with autologous
ps
SusCS SecCS
12 mo 24 mo 12 mo 24 mo
49%  5% 44%  6% 59%  5% 58%  5%
72%  6% 70%  6% 82%  5% 82%  5%
46%  6% 39%  6% 59%  6% 51%  6%
.002 .002
65%  9% 65%  9% 76%  8% 76%  8%
69%  15% 57%  17% 80%  13% 80%  13%
36%  12% 27%  12% 55%  11% 47%  12%
.049 .075
42%  6% 35%  7% 52%  6% 50%  6%
72%  6% 72%  6% 82%  5% 82%  5%
51%  7% 43%  7% 61%  7% 53%  7%
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OCI f-TER
12 mo 24 mo 12 mo 24 mo
73%  5% 69%  5% 75%  6% 65%  7%
81%  5% 81%  5% 89%  4% 83%  5%
63%  6% 55%  7% 67%  7% 64%  7%
.03 .03
90%  6% 90%  6% 87%  7% 87%  7%
80%  13% 80%  13% 76%  15% 64%  17%
55%  11% 47%  12% 54%  15% 54%  15%
.005 .04
66%  6% 60%  7% 69%  7% 55%  9%
81%  5% 81%  5% 87%  5% 87%  5%
68%  7% 59%  8% 72%  7% 67%  8%.055 .02
